Hypertension-attributed nephropathy: what's in a name?

[1]  J. Lima,et al.  The Multiethnic Study of Atherosclerosis. , 2016, Global heart.

[2]  Catherine C. Robertson,et al.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects. , 2016, Journal of the American Society of Nephrology : JASN.

[3]  K. Skorecki,et al.  APOL1 nephropathy: from gene to mechanisms of kidney injury. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  D. Vandorpe,et al.  BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins. , 2015, American journal of physiology. Cell physiology.

[5]  B. Freedman,et al.  Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells , 2015, Journal of Lipid Research.

[6]  Alan B Leichtman,et al.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  K. Skorecki,et al.  Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1. , 2015, American journal of physiology. Cell physiology.

[8]  A. Ashley-Koch,et al.  In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress , 2015, PLoS genetics.

[9]  C. Winkler,et al.  APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  S. Engelmann,et al.  A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. , 2015, Journal of the American Society of Nephrology : JASN.

[11]  Mardge H. Cohen,et al.  APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  Nicholette D. Palmer,et al.  Apolipoprotein L1 Gene Variants in Deceased Organ Donors Are Associated With Renal Allograft Failure , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  K. Hruska,et al.  Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease , 2015, Pediatric Nephrology.

[14]  A. Meyrier.  Nephrosclerosis: A Term in Quest of a Disease , 2015, Nephron.

[15]  Patrick Blake,et al.  Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine , 2015, Journal of Clinical Bioinformatics.

[16]  M. Ramsay,et al.  APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. , 2015, Journal of the American Society of Nephrology : JASN.

[17]  S. Textor,et al.  Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  C. Winkler,et al.  HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment , 2015, Nature Reviews Nephrology.

[19]  B. Freedman,et al.  Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines. , 2015, Journal of the American Society of Nephrology.

[20]  C. Winkler,et al.  Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. , 2015, Journal of the American Society of Nephrology : JASN.

[21]  Andrew D. Johnson,et al.  Genome-wide association study of kidney function decline in individuals of European descent , 2014, Kidney international.

[22]  K. Skorecki,et al.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[23]  Steven Wolinsky,et al.  The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  M. Ross.  Advances in the pathogenesis of HIV-associated kidney diseases. , 2014, Kidney international.

[25]  V. D’Agati,et al.  Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 , 2014, Kidney international.

[26]  J. Williamson,et al.  The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) , 2014, Clinical trials.

[27]  R. Bosch,et al.  Plasma apolipoprotein L1 levels do not correlate with CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[28]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[29]  John D Reveille,et al.  End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 , 2014, Arthritis & rheumatology.

[30]  L. Brewster,et al.  What role does African ancestry play in how hypertensive patients respond to certain antihypertensive drug therapy? , 2014, Expert opinion on pharmacotherapy.

[31]  Barry I. Freedman,et al.  APOL1 risk variants, race, and progression of chronic kidney disease. , 2013, The New England journal of medicine.

[32]  Ishir Bhan,et al.  Vitamin D-binding protein and vitamin D status of black Americans and white Americans. , 2013, The New England journal of medicine.

[33]  Nicholette D. Palmer,et al.  APOL1 and progression of nondiabetic nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.

[34]  J. Kopp.  Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder , 2013, Current opinion in nephrology and hypertension.

[35]  G. Genovese,et al.  APOL1 variants and kidney disease in people of recent African ancestry , 2013, Nature Reviews Nephrology.

[36]  Nicholas A. Johnson,et al.  Association of DXA-derived bone mineral density and fat mass with African ancestry. , 2013, The Journal of clinical endocrinology and metabolism.

[37]  Kathleen F. Kerr,et al.  Admixture Mapping of Coronary Artery Calcified Plaque in African Americans With Type 2 Diabetes Mellitus , 2013, Circulation. Cardiovascular genetics.

[38]  Sylvia Stracke,et al.  Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. , 2012, Human molecular genetics.

[39]  Ronald Cornet,et al.  New primary renal diagnosis codes for the ERA-EDTA , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  Y. J. Kim,et al.  Meta-analysis identifies multiple loci associated with kidney function–related traits in east Asian populations , 2012, Nature Genetics.

[41]  G. Genovese,et al.  The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5‐Year Allograft Survival , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  B. Astor,et al.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.

[43]  Loreto Gesualdo,et al.  Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis , 2012, PLoS genetics.

[44]  B. Freedman,et al.  Target Organ Damage in African American Hypertension: Role of APOL1 , 2012, Current Hypertension Reports.

[45]  J. O'Toole,et al.  APOL1 localization in normal kidney and nondiabetic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[46]  Giulio Genovese,et al.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[47]  Nicholette D. Palmer,et al.  Differential Effects of MYH9 and APOL1 Risk Variants on FRMD3 Association with Diabetic ESRD in African Americans , 2011, PLoS genetics.

[48]  M. Rocco,et al.  The APOL1 Gene and Allograft Survival after Kidney Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[49]  Antony Vinh,et al.  Inflammation, Immunity, and Hypertension , 2011, Hypertension.

[50]  L. Lerman,et al.  Renovascular hypertension and ischemic nephropathy. , 2010, American journal of hypertension.

[51]  Keith C. Norris,et al.  Intensive blood-pressure control in hypertensive chronic kidney disease. , 2010, The New England journal of medicine.

[52]  C. Winkler,et al.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. , 2010, Journal of the American Society of Nephrology : JASN.

[53]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[54]  L. Appel,et al.  Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. , 2010, Journal of the American Society of Nephrology : JASN.

[55]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[56]  Uwe Völker,et al.  New loci associated with kidney function and chronic kidney disease , 2010, Nature Genetics.

[57]  Mark N. Wass,et al.  Genetic loci influencing kidney function and chronic kidney disease , 2010, Nature Genetics.

[58]  Hui Geng,et al.  Acute kidney injury: a springboard for progression in chronic kidney disease. , 2010, American journal of physiology. Renal physiology.

[59]  J. Pankow,et al.  Genetic Ancestry Is Associated With Subclinical Cardiovascular Disease in African-Americans and Hispanics From the Multi-Ethnic Study of Atherosclerosis , 2009, Circulation. Cardiovascular genetics.

[60]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[61]  Yurii S. Aulchenko,et al.  Multiple loci associated with indices of renal function and chronic kidney disease , 2009, Nature Genetics.

[62]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[63]  C. Basile.  The long-term prognosis of acute kidney injury: acute renal failure as a cause of chronic kidney disease. , 2008, Journal of nephrology.

[64]  D. Reich,et al.  Genetic markers for ancestry are correlated with body composition traits in older African Americans , 2007, Osteoporosis International.

[65]  M. Budoff,et al.  Ethnic differences of the presence and severity of coronary atherosclerosis. , 2006, Atherosclerosis.

[66]  N. Reichek.  The Multi-Ethnic Study of Atherosclerosis (MESA) and myocardial function: where is the boundary between risk factor and disease? , 2006, Journal of the American College of Cardiology.

[67]  D. Jacobs,et al.  Racial/Ethnic differences in subclinical atherosclerosis among adults with diabetes: the multiethnic study of atherosclerosis. , 2005, Diabetes care.

[68]  F. Hsu,et al.  The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study , 2005, Diabetologia.

[69]  B. Freedman,et al.  Population-Based Screening for Family History of End-Stage Renal Disease among Incident Dialysis Patients , 2005, American Journal of Nephrology.

[70]  J. Maccluer,et al.  Kidney disease among the Zuni Indians: the Zuni Kidney Project. , 2005, Kidney international. Supplement.

[71]  R. Detrano,et al.  Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[72]  Quan Dong Nguyen,et al.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.

[73]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[74]  R. Kronmal,et al.  Relationship Between Coronary Artery Calcification and Other Measures of Subclinical Cardiovascular Disease in Older Adults , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[75]  C. Marcantoni,et al.  Hypertensive nephrosclerosis in African Americans versus Caucasians. , 2002, Kidney international.

[76]  B. Freedman.  End-stage renal failure in African Americans: insights in kidney disease susceptibility. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[77]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[78]  S. Iyengar,et al.  Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[79]  B. Freedman,et al.  Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[80]  H. S. Kim,et al.  Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[81]  P. Whelton,et al.  Familial aggregation of renal disease in a population-based case-control study. , 1998, Journal of the American Society of Nephrology : JASN.

[82]  B. Freedman,et al.  Family history of end-stage renal disease among incident dialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.

[83]  K. Chan,et al.  Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[84]  B. Freedman,et al.  Familial clustering of end-stage renal disease in blacks with lupus nephritis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[85]  D. Warnock,et al.  Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[86]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[87]  B. Freedman,et al.  The link between hypertension and nephrosclerosis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[88]  B. Freedman.  Renal microvascular susceptibility in African American pedigrees. , 1993, Transplantation proceedings.

[89]  B. Freedman,et al.  The familial risk of end-stage renal disease in African Americans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[90]  D. Adu,et al.  Renal biopsy findings in hypertensive patients with proteinuria , 1992, The Lancet.

[91]  Tracy Rp,et al.  Thrombosis and cardiovascular risk in the elderly. , 1992 .

[92]  R. Luke,et al.  Changing patterns of end-stage renal disease due to hypertension. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[93]  L. Svetkey,et al.  Similar Prevalence of Renovascular Hypertension in Selected Blacks and Whites , 1991, Hypertension.

[94]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[95]  M. Blaufox,et al.  Prognostic Value of Serum Creatinine and Effect of Treatment of Hypertension on Renal Function: Results From the Hypertension Detection and Follow‐up Program , 1989 .

[96]  H. Dustan,et al.  Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.

[97]  M. Hughson,et al.  Mesangiopathic glomerulonephritis in Zuni (New Mexico) Indians. , 1989, Archives of pathology & laboratory medicine.

[98]  C. Grim,et al.  A familial risk of chronic renal failure among blacks on dialysis? , 1988, Journal of clinical epidemiology.

[99]  G. Ramirez,et al.  Proteinuria in hypertension. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[100]  L. Kuller,et al.  Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. , 1984, American heart journal.

[101]  T. A. Keith.  Renovascular Hypertension in Black Patients , 1982, Hypertension.

[102]  THE AUSTRALIAN THERAPEUTIC TRIAL IN MILD HYPERTENSION Report by the Management Committee , 1980, The Lancet.

[103]  M. Maxwell,et al.  Clinical characteristics of renovascular hypertension. , 1972, JAMA.

[104]  Barry I Freedman,et al.  Histopathologic findings associated with APOL1 risk variants in chronic kidney disease , 2015, Modern Pathology.

[105]  Steven D. Hochman,et al.  Revascularization versus Medical Therapy for Renal Artery Stenosis , 2015 .

[106]  K. Skorecki,et al.  Hypertension-misattributed kidney disease in African Americans. , 2013, Kidney international.

[107]  Jinlai Liu,et al.  Systolic Blood Pressure Intervention Trial (SPRINT) , 2013 .

[108]  Audrey Y. Chu,et al.  Genome-wide association and functional follow-up reveals new loci for kidney function , 2012 .

[109]  M. Smith,et al.  The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults , 2011 .

[110]  R. Elston,et al.  Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). , 2005, Kidney international.

[111]  P. O'Malley,et al.  The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. , 2003, Journal of the American College of Cardiology.

[112]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[113]  J. Breyer,et al.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. , 1997, Kidney international.

[114]  P. Whelton,et al.  Diagnosis of hypertensive end-stage renal disease: effect of patient's race. , 1995, American journal of epidemiology.

[115]  B. Freedman,et al.  Renal biopsy findings in presumed hypertensive nephrosclerosis. , 1994, American journal of nephrology.

[116]  R. Tracy,et al.  Thrombosis and cardiovascular risk in the elderly. , 1992, Archives of pathology & laboratory medicine.

[117]  L. Svetkey,et al.  Racial differences in the incidence and progression of renal diseases. , 1991, Kidney international.

[118]  B. Kasinath,et al.  Marked proteinuria in hypertensive nephrosclerosis. , 1985, American journal of nephrology.

[119]  L. Burpee.  Report of the Management Committee , 1926 .